Symbols

HOTH

Hoth Therapeutics·NASDAQ

--(--)

HOTH Profile

Hoth Therapeutics, Inc.

A clinical-stage biopharmaceutical company focused on developing the treatment for cancer, anaphylaxis, traumatic brain injury, ischemic stroke, or other neuroinflammatory diseases

Industry

Pharmaceutical

Established Date

05/16/2017

Listing Date

02/15/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.hoththerapeutics.com

Security Type

Common stock

Office address

720 Monroe Street Suite E514 Hoboken NJ 07030

Business

Introduction

Hoth Therapeutics, Inc., was incorporated under the laws of the State of Nevada on May 16, 2017. The company is a clinical-stage biopharmaceutical company focused on developing next-generation therapies for unmet medical needs. Its R&D pipeline includes drug candidates for tumor treatment-related side effects, mast cell-derived cancers, neuroinflammatory diseases and other indications.